Cross-referencing clinical data
A pairing appears on this page only when a trial gave both ingredients together and measured the result. Isobutylamides has none that clears that bar.
Stitching two separate single-ingredient studies into a pairing is the one thing this engine will not do. When a study of the combination itself holds up at source, it lands here with its citation.
No invented synergy. Where actives were studied on their own rather than together, the record shows each on its own evidence, never a combined effect no trial measured.
Research strength. Research strength says how much work stands behind the combination. It is never a product score.
Independent record. Every finding is cited to a named trial, dated, and never written by the brand.
20 pairings are live across the library today. Checked 20 July 2026.
No study gave these as a pair, so they are not in the card above. But the reason they belong together is settled biochemistry, not a guess, so it is worth knowing.
Piperine is an alkylamide with a piperidine head group, and echinacea isobutylamides differ mainly in the amine terminus. Both act on TRPV1, which is why both produce the tingling and warming sensation on the tongue. Combining them stacks the same receptor activity rather than adding a distinct mechanism. Piperine's separate role as a CYP3A4 and UGT inhibitor is a different matter and belongs to piperine, not to the isobutylamide class.
Isobutylamides are lipophilic and dissolve poorly in water, which is why echinacea preparations aimed at them are made with high-percentage ethanol or supplied in oil. A lipid vehicle keeps them in solution and supports micellar uptake. Dry powdered whole-herb preparations carry far less alkylamide in soluble form than a hydroalcoholic extract of the same plant weight. Vehicle choice changes what actually gets delivered.
Gingerols and shogaols act on TRPV1 much as alkylamides do, which is the shared basis of the pungency both produce. Formulated together the sensory effect compounds noticeably. Whether the receptor-level overlap translates into anything beyond sensation at oral doses has not been established. The pairing is common in throat and oral-delivery formats for the sensation itself.
Alkylamides undergo rapid phase I oxidation and phase II conjugation after absorption, and high-dose flavonoids compete for the same conjugating capacity. In principle this could raise alkylamide exposure. It has not been shown at the intakes people actually use. Read it as a theoretical pharmacokinetic overlap, not a formulation strategy.
Isobutylamides degrade over storage through oxidation and isomerisation of their conjugated diene and diyne systems, and loss is measurable in liquid extracts within months at room temperature. Antioxidants in the formulation slow that loss. This preserves the assayed alkylamide figure at end of shelf life. It is a stability measure and nothing more.
Zinc lozenges and alkylamide-bearing echinacea preparations appear together in seasonal formulas, and both produce distinct oral sensory effects. There is no shared mechanism between a metal ion and a lipophilic amide. The pairing is formulation convention driven by category rather than by chemistry. Stating it as a synergy would overstate what is known.
Elderberry anthocyanins and echinacea alkylamides are routinely blended in the same seasonal products. The two have no mechanistic overlap: one is a water-soluble pigment glycoside, the other a lipophilic amide. Combination products have been studied as combinations, so nothing in that work isolates the alkylamide contribution. This is formulation convention.
Nothing specific on file for Isobutylamides. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.